In this issue:
Cumulative alendronate dose and the long-term risk of femur fractures
Thiazolidinediones and fracture risk
Sex hormones and BMD in older men
Failure to perceive increased fracture risk in older women
Predicted hip fracture incidence in NZ
Patterns of treatment after fracture in Australian men
Odanacatib improves BMD in postmenopausal women
Evaluation of FRAX and Garvan fracture risk calculators
Calcium supplementation and the risk of atherosclerotic vascular disease
Height loss is an indicator for vertebral fractures
Please login below to download this issue (PDF)